Engineers at MIT developed a new way to accomplish purification while manufacturing protein drugs, potentially reducing costs of production. The researchers say the manufacturing process represents one of the most expensive steps in manufacturing protein drugs. These kinds of drugs include antibodies or insulin. Purification involves isolating the protein from the bioreactor used to produce…
Engineered yeast could be key for more affordable COVID-19 vaccines
Researchers at MIT and Beth Israel Deaconess Medical Center are exploring a yeast-based alternative to RNA vaccines. A new paper highlights a vaccine, which comprises fragments of the SARS-CoV-2 spike protein arrayed on a virus-like particle, that reportedly elicited a strong immune response and protected animals against viral challenge, according to a post on MIT’s…